| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RANGAP1 RASGRF2 PCP2 SIRPG FBXO8 TIAM1 ARHGAP31 ARHGAP12 DEPDC5 VAV3 RIMS1 RPGR ARHGAP18 SIPA1L2 | 7.38e-05 | 507 | 163 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RANGAP1 RASGRF2 PCP2 SIRPG FBXO8 TIAM1 ARHGAP31 ARHGAP12 DEPDC5 VAV3 RIMS1 RPGR ARHGAP18 SIPA1L2 | 7.38e-05 | 507 | 163 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.75e-04 | 143 | 163 | 7 | GO:0017124 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | RASGRF2 PICALM CYRIB RASIP1 FBXO8 TIAM1 ARHGAP31 ARHGAP12 NGF VAV3 ARHGAP18 SIPA1L2 | 1.25e-05 | 333 | 161 | 12 | GO:0051056 |
| GeneOntologyCellularComponent | cell cortex | RIMS3 SPTBN1 PPFIA3 SHROOM2 WDPCP AXIN1 PARD6B MACF1 RIMS1 SEPTIN7 SNX9 ENO2 | 3.81e-05 | 371 | 164 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | pericentriolar material | 6.46e-05 | 28 | 164 | 4 | GO:0000242 | |
| GeneOntologyCellularComponent | cell projection membrane | SPTBN1 ADGRV1 ACE BBS9 CDKL5 TIAM1 SYNJ2 PROM2 CD36 CSPG4 MACF1 SLC7A5 | 1.58e-04 | 431 | 164 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | cell leading edge | SPTBN1 ADGRV1 CDKL5 LDB1 TIAM1 SYNJ2 ARHGAP31 CSPG4 UNC5C MACF1 PRKCI ARHGAP18 SNX9 | 1.65e-04 | 500 | 164 | 13 | GO:0031252 |
| Domain | - | 2.13e-05 | 95 | 165 | 7 | 2.60.120.200 | |
| Domain | EGF_CA | 1.14e-04 | 86 | 165 | 6 | PF07645 | |
| Domain | Laminin_G | 1.59e-04 | 58 | 165 | 5 | IPR001791 | |
| Domain | Prepro-melanin_conc_hormone | 2.31e-04 | 3 | 165 | 2 | IPR005456 | |
| Domain | Pro-MCH | 2.31e-04 | 3 | 165 | 2 | PF05824 | |
| Domain | EGF_3 | 2.48e-04 | 235 | 165 | 9 | PS50026 | |
| Domain | EGF-like_dom | 3.79e-04 | 249 | 165 | 9 | IPR000742 | |
| Domain | LRRC37AB_C | 4.60e-04 | 4 | 165 | 2 | IPR029423 | |
| Domain | LRRC37AB_C | 4.60e-04 | 4 | 165 | 2 | PF14914 | |
| Domain | LRRC37_N | 4.60e-04 | 4 | 165 | 2 | IPR032754 | |
| Domain | LRRC37 | 4.60e-04 | 4 | 165 | 2 | PF15779 | |
| Domain | LRRC37A/B-like | 4.60e-04 | 4 | 165 | 2 | IPR015753 | |
| Domain | ConA-like_dom | 7.47e-04 | 219 | 165 | 8 | IPR013320 | |
| Domain | EGF_CA | 7.54e-04 | 122 | 165 | 6 | SM00179 | |
| Domain | AWS | 7.62e-04 | 5 | 165 | 2 | SM00570 | |
| Domain | TSP_3 | 7.62e-04 | 5 | 165 | 2 | PF02412 | |
| Domain | AWS | 7.62e-04 | 5 | 165 | 2 | PS51215 | |
| Domain | TSP3 | 7.62e-04 | 5 | 165 | 2 | PS51234 | |
| Domain | AWS_dom | 7.62e-04 | 5 | 165 | 2 | IPR006560 | |
| Domain | TSP_CTER | 7.62e-04 | 5 | 165 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 7.62e-04 | 5 | 165 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 7.62e-04 | 5 | 165 | 2 | IPR028974 | |
| Domain | - | 7.62e-04 | 5 | 165 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 7.62e-04 | 5 | 165 | 2 | IPR008859 | |
| Domain | TSP_C | 7.62e-04 | 5 | 165 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 7.62e-04 | 5 | 165 | 2 | IPR003367 | |
| Domain | EGF-like_Ca-bd_dom | 8.21e-04 | 124 | 165 | 6 | IPR001881 | |
| Domain | STAT_TF_DNA-bd_sub | 1.58e-03 | 7 | 165 | 2 | IPR012345 | |
| Domain | STAT | 1.58e-03 | 7 | 165 | 2 | IPR001217 | |
| Domain | STAT_int | 1.58e-03 | 7 | 165 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.58e-03 | 7 | 165 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.58e-03 | 7 | 165 | 2 | PF02864 | |
| Domain | STAT_int | 1.58e-03 | 7 | 165 | 2 | PF02865 | |
| Domain | - | 1.58e-03 | 7 | 165 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.58e-03 | 7 | 165 | 2 | PF01017 | |
| Domain | - | 1.58e-03 | 7 | 165 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.58e-03 | 7 | 165 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.58e-03 | 7 | 165 | 2 | IPR015988 | |
| Domain | - | 1.58e-03 | 7 | 165 | 2 | 2.60.40.630 | |
| Pubmed | RANGAP1 GAK SYNM ATP13A1 POLR2B SPTBN1 RCN2 PON2 LRRC40 SCAMP2 CEP192 VARS2 ANKLE2 CACTIN TBC1D31 TIAM1 TRABD ZNF644 VPS13A CDK5RAP2 MACF1 SLC7A5 PRKCI SAMM50 SIPA1L2 ATP2A2 | 1.38e-08 | 1487 | 168 | 26 | 33957083 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANGAP1 KIAA0232 POLR2B RCN2 CEP192 GTPBP1 ACE ANKLE2 ARCN1 PPM1A SPAG5 TBC1D31 SYNJ2 ARHGAP12 SEPTIN7 SIPA1L2 SNX9 CNN2 | 1.91e-07 | 853 | 168 | 18 | 28718761 |
| Pubmed | FAT4 SYNM BEND3 APOB CEP192 ARCN1 CDKL5 LIPE ZC3H4 ZBED6 UNC5C VPS13A MKI67 OSBPL9 CDK5RAP2 SLC7A5 RPGR | 2.58e-07 | 777 | 168 | 17 | 35844135 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 14726409 | ||
| Pubmed | RANGAP1 POLR2B SPTBN1 RCN2 LMTK2 CEP192 PPFIA3 ANKLE2 PPM1A NSD3 CACTIN TBC1D31 TIAM1 VPS13A MKI67 OTUD4 CDK5RAP2 PRKCI ATP2A2 | 8.65e-07 | 1049 | 168 | 19 | 27880917 | |
| Pubmed | Cdc42 deficiency causes Sonic hedgehog-independent holoprosencephaly. | 9.14e-07 | 16 | 168 | 4 | 17050694 | |
| Pubmed | POLR2B SPTBN1 NSD1 LMTK2 APOB CEP192 NCSTN TSNAX KLF4 SHROOM2 ANKLE2 SPAG5 TBC1D31 WDHD1 UNC5C OTUD4 CDK5RAP2 MACF1 QSER1 | 1.40e-06 | 1084 | 168 | 19 | 11544199 | |
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 1.52e-06 | 18 | 168 | 4 | 33108146 | |
| Pubmed | Fanconi DNA repair pathway is required for survival and long-term maintenance of neural progenitors. | 2.19e-06 | 6 | 168 | 3 | 18239686 | |
| Pubmed | Fatty acid transport protein 2 reprograms neutrophils in cancer. | 2.19e-06 | 6 | 168 | 3 | 30996346 | |
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 17633563 | ||
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 16059920 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RANGAP1 SPTBN1 PICALM CDKL5 STXBP6 SYNJ2 PROM2 MACF1 SEPTIN7 ARHGAP18 SNX9 HCFC1 CNN2 | 4.10e-06 | 565 | 168 | 13 | 25468996 |
| Pubmed | RANGAP1 GAK ATP13A1 SPTBN1 ANKLE2 ARCN1 VPS13A OSBPL9 SLC7A5 SNX9 HCFC1 CNN2 ALG13 | 4.34e-06 | 568 | 168 | 13 | 37774976 | |
| Pubmed | NES RANGAP1 SPTBN1 NSD1 PPFIA3 PICALM CYRIB SIRPG LDB1 ZC3H4 OTUD4 CDK5RAP2 MACF1 PRKCI RIMS1 QSER1 SEPTIN7 | 4.74e-06 | 963 | 168 | 17 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES KIAA0232 NTRK3 SPTBN1 LMTK2 CEP192 NARS2 PPM1A NSD3 ZNF106 TIAM1 SYNJ2 MACF1 PRKCI SIPA1L2 OTOG | 4.83e-06 | 861 | 168 | 16 | 36931259 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANGAP1 ZBTB20 POLR2B NSD1 BEND3 KLF4 GTF3C4 NSD3 FANCA ZSCAN29 ZNF106 CACTIN CDC40 ZNF644 MKI67 SLC7A5 QSER1 ATP2A2 TAF1L HCFC1 | 4.87e-06 | 1294 | 168 | 20 | 30804502 |
| Pubmed | SYNM ANKLE2 PICALM AXIN1 TBC1D31 MKI67 SECISBP2 MACF1 SIPA1L2 | 5.86e-06 | 263 | 168 | 9 | 34702444 | |
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 31772009 | ||
| Pubmed | The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. | 9.10e-06 | 9 | 168 | 3 | 12237455 | |
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 28705869 | ||
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 1.09e-05 | 60 | 168 | 5 | 12787561 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 NRIP1 ZBTB20 KIAA0232 PON2 CEP192 TSNAX ADGRV1 SHROOM2 STAT5B LDB1 SYNJ2 PROM2 OSBPL9 SLC9A7 MACF1 PRKCI SAMM50 RIMS1 QSER1 SNX9 | 1.12e-05 | 1489 | 168 | 21 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SYNM POLR2B BEND3 LRRC40 VARS2 ANKLE2 NARS2 CDC40 ZC3H4 NUP37 TRABD ZNF644 ARHGAP12 VPS13A OSBPL9 SECISBP2 CDK5RAP2 PRKCI SAMM50 ATP2A2 ALG13 | 1.20e-05 | 1496 | 168 | 21 | 32877691 |
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 16884701 | ||
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 20368359 | ||
| Pubmed | G1 arrest and differentiation can occur independently of Rb family function. | 1.30e-05 | 10 | 168 | 3 | 21059851 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANGAP1 RCN2 CEP192 GTF3C4 ARCN1 SPAG5 PARD6B ZNF106 CDC40 SYNJ2 ZC3H4 NUP37 ZNF644 MKI67 CDK5RAP2 PRKCI SAMM50 HCFC1 | 1.34e-05 | 1155 | 168 | 18 | 20360068 |
| Pubmed | NES GAK ATP13A1 POLR2B RCN2 GTF3C4 ZNF106 TBC1D31 WDHD1 SYNJ2 SECISBP2 SLC7A5 QSER1 HCFC1 | 1.43e-05 | 733 | 168 | 14 | 34672954 | |
| Pubmed | 1.49e-05 | 31 | 168 | 4 | 15217342 | ||
| Pubmed | RANGAP1 GAK POLR2B NSD1 BEND3 GTF3C4 ARCN1 NSD3 OSBPL9 QSER1 SNX9 HCFC1 | 1.62e-05 | 549 | 168 | 12 | 38280479 | |
| Pubmed | 1.78e-05 | 11 | 168 | 3 | 20439457 | ||
| Pubmed | 1.93e-05 | 33 | 168 | 4 | 33951080 | ||
| Pubmed | 1.93e-05 | 33 | 168 | 4 | 30037926 | ||
| Pubmed | RANGAP1 SPTBN1 PON2 NCSTN ARCN1 NUP37 ARHGAP12 VPS13A OTUD4 SLC7A5 SAMM50 ATP2A2 ALG13 | 2.03e-05 | 657 | 168 | 13 | 36180527 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24146927 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23151802 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 2.32e-05 | 2 | 168 | 2 | 31443474 | |
| Pubmed | CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding. | 2.32e-05 | 2 | 168 | 2 | 25555908 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24606907 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 2.32e-05 | 2 | 168 | 2 | 21127177 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16289657 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 2.32e-05 | 2 | 168 | 2 | 21431790 | |
| Pubmed | Krüppel-like factor 4 regulates amyloid-β (Aβ)-induced neuroinflammation in Alzheimer's disease. | 2.32e-05 | 2 | 168 | 2 | 28189744 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 7720707 | ||
| Pubmed | Amygdala kindling induces nestin expression in the leptomeninges of the neocortex. | 2.32e-05 | 2 | 168 | 2 | 23305954 | |
| Pubmed | ZBTB20 Regulates SERCA2a Activity and Myocardial Contractility Through Phospholamban. | 2.32e-05 | 2 | 168 | 2 | 38166470 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12217382 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31599926 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 10594041 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21036145 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 10486277 | ||
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 2.32e-05 | 2 | 168 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 2.32e-05 | 2 | 168 | 2 | 30377054 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23565285 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18322245 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 2.32e-05 | 2 | 168 | 2 | 23773921 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 2.32e-05 | 2 | 168 | 2 | 24878107 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 7568026 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29846435 | ||
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 2.32e-05 | 2 | 168 | 2 | 10486314 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36719147 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 2.32e-05 | 2 | 168 | 2 | 29460051 | |
| Pubmed | HIF-2α-induced upregulation of CD36 promotes the development of ccRCC. | 2.32e-05 | 2 | 168 | 2 | 36252650 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28606561 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36609091 | ||
| Pubmed | Increased cortical expression of two synaptogenic thrombospondins in human brain evolution. | 2.32e-05 | 2 | 168 | 2 | 17182969 | |
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 2.32e-05 | 2 | 168 | 2 | 12393407 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21178171 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 2.32e-05 | 2 | 168 | 2 | 20233708 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17447893 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 8268913 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16115927 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28183448 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11867689 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15340066 | ||
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 2.32e-05 | 2 | 168 | 2 | 12901872 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19445653 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11070051 | ||
| Pubmed | Serum angiopoietin-2 and CRP levels during COPD exacerbations. | 2.32e-05 | 2 | 168 | 2 | 24102428 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 2.32e-05 | 2 | 168 | 2 | 12421978 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19966185 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21704724 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24838548 | ||
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 2.32e-05 | 2 | 168 | 2 | 8732682 | |
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 2.32e-05 | 2 | 168 | 2 | 32281944 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23465551 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27367207 | ||
| Pubmed | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. | 2.32e-05 | 2 | 168 | 2 | 16493008 | |
| Pubmed | Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. | 2.32e-05 | 2 | 168 | 2 | 15677477 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16757175 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15677453 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17317776 | ||
| Pubmed | The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. | 2.32e-05 | 2 | 168 | 2 | 32041920 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17976521 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25896118 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22319210 | ||
| Interaction | C2CD4B interactions | 1.40e-06 | 44 | 163 | 6 | int:C2CD4B | |
| Interaction | EGLN3 interactions | RANGAP1 POLR2B RCN2 LRRC40 CEP192 ANKLE2 GTF3C4 ARCN1 AXIN1 ZNF106 WDHD1 TRABD ZNF644 OTUD4 SECISBP2 CDK5RAP2 SLC7A5 MTBP SAMM50 SIPA1L2 SNX9 ATP2A2 HCFC1 CNN2 EPAS1 ALG13 | 1.57e-05 | 1296 | 163 | 26 | int:EGLN3 |
| Interaction | NUP210P1 interactions | 2.17e-05 | 42 | 163 | 5 | int:NUP210P1 | |
| Cytoband | 5q13 | 1.20e-06 | 22 | 168 | 4 | 5q13 | |
| GeneFamily | Cadherin related | 1.33e-04 | 17 | 108 | 3 | 24 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 2.10e-04 | 4 | 108 | 2 | 833 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.37e-04 | 206 | 108 | 7 | 682 | |
| GeneFamily | PDZ domain containing | 3.02e-04 | 152 | 108 | 6 | 1220 | |
| GeneFamily | Intermediate filaments Type IV | 5.22e-04 | 6 | 108 | 2 | 611 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN | ZBTB20 MOGAT2 LMNTD2 SCAMP2 WDPCP GTF3C4 RNF157 TIAM1 SYNJ2 CD36 PRKCI | 7.37e-08 | 200 | 168 | 11 | M9382 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | NES ANGPT2 SPTBN1 PON2 KLF4 ACE BBS9 RASIP1 NID1 SLC7A5 SAMM50 ARHGAP18 EPAS1 HYAL2 | 1.03e-06 | 440 | 168 | 14 | M39039 |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | PRUNE2 FAT4 SYNM ITGA10 KLF4 SHROOM2 CDK5RAP2 NID1 RIMS1 ENO2 | 6.67e-06 | 257 | 168 | 10 | M13867 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | ZBTB20 SPTBN1 KLF4 ACE RASIP1 TIAM1 MACF1 NID1 SLC7A5 LTB ATP2A2 EPAS1 | 1.91e-05 | 422 | 168 | 12 | M7396 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL | 2.08e-05 | 52 | 168 | 5 | M45792 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | 3.13e-05 | 189 | 168 | 8 | M4199 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | ZBTB20 SPTBN1 KLF4 ACE RASIP1 TIAM1 MACF1 NID1 SLC7A5 LTB ATP2A2 EPAS1 | 3.15e-05 | 444 | 168 | 12 | MM1051 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 ZBTB20 POLR2B ANKLE2 PICALM THBS2 TBC1D31 WDHD1 TIAM1 SYNJ2 ZC3H4 ARHGAP12 VPS13A OTUD4 MACF1 PRKCI RPGR | 3.83e-05 | 856 | 168 | 17 | M4500 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 3.92e-05 | 195 | 168 | 8 | M4201 | |
| Coexpression | HAN_SATB1_TARGETS_DN | NES RBL2 ITGA10 SHROOM2 ANKLE2 L3MBTL1 WDHD1 STXBP6 SYNJ2 ASTN1 QSER1 | 4.41e-05 | 388 | 168 | 11 | M15491 |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN | 4.68e-05 | 200 | 168 | 8 | M8600 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_UP | 6.64e-05 | 66 | 168 | 5 | M15476 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 8.36e-05 | 161 | 168 | 7 | M7728 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | LIAS RASGRF2 RBL2 POLR2B SPTBN1 RCN2 BBS9 RNF157 SIRPG TBC1D31 ARHGAP12 SKAP1 VPS13A SLC9A7 MACF1 CARD11 LTB ENO2 | 9.27e-05 | 1012 | 168 | 18 | M40864 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_200 | 1.06e-05 | 38 | 164 | 5 | gudmap_developingGonad_e18.5_epididymis_200_k3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ANGPT2 SPTBN1 ITGA10 PON2 RASIP1 NID1 SLC7A5 SAMM50 RPGR EPAS1 HYAL2 | 2.68e-10 | 198 | 168 | 11 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES SPTBN1 ITGA10 PON2 KLF4 ACE RASIP1 STXBP6 CD36 EPAS1 HYAL2 | 2.83e-10 | 199 | 168 | 11 | 5f67ea58512856cbdcef759088a5869720a947a8 |
| ToppCell | medial-Endothelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | NES SPTBN1 ITGA10 PON2 KLF4 ACE RASIP1 STXBP6 RPGR EPAS1 HYAL2 | 2.98e-10 | 200 | 168 | 11 | e889b593c2ae53c42944213ce8672cd886917105 |
| ToppCell | medial-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | NES SPTBN1 ITGA10 PON2 KLF4 ACE RASIP1 STXBP6 RPGR EPAS1 HYAL2 | 2.98e-10 | 200 | 168 | 11 | 70440db2d8be1e29aeb34ea5e8ac72641b5c056f |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | NES SPTBN1 ITGA10 PON2 KLF4 ACE RASIP1 STXBP6 ARHGAP18 EPAS1 HYAL2 | 2.98e-10 | 200 | 168 | 11 | 6567683f8f534310fecb44a6721909183fdc15ca |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | NES SPTBN1 PON2 KLF4 ACE RASIP1 STXBP6 CD36 RPGR EPAS1 HYAL2 | 2.98e-10 | 200 | 168 | 11 | 3b07cf1a4dff2e868f52382681a2030c1248caed |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | SPTBN1 ITGA10 ACE SHROOM2 RASIP1 STXBP6 ARHGAP31 VAV3 SIPA1L2 EPAS1 | 1.78e-09 | 180 | 168 | 10 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NES ITGA10 KLF4 ACE RASIP1 STXBP6 CSPG4 ARHGAP18 EPAS1 HYAL2 | 2.57e-09 | 187 | 168 | 10 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES SPTBN1 ITGA10 ACE SHROOM2 RASIP1 STXBP6 ARHGAP31 EPAS1 HYAL2 | 2.85e-09 | 189 | 168 | 10 | b6b4da51bc7f2c13a2f940540fdc61027d084835 |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | FAT4 SPTBN1 ITGA10 PON2 RASIP1 STXBP6 RIMS1 RPGR EPAS1 HYAL2 | 3.67e-09 | 194 | 168 | 10 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | SPTBN1 ITGA10 PON2 ACE SHROOM2 RASIP1 STXBP6 ARHGAP31 SIPA1L2 EPAS1 | 4.05e-09 | 196 | 168 | 10 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | FAT4 SPTBN1 PON2 SHROOM2 RASIP1 STXBP6 ARHGAP31 RPGR ARHGAP18 EPAS1 | 4.05e-09 | 196 | 168 | 10 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.46e-09 | 198 | 168 | 10 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.91e-09 | 200 | 168 | 10 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SPTBN1 KLF4 ACE RASIP1 STXBP6 MACF1 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | 5c092b2ecc081b5d04476c56333c338cd89ab984 |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | SPTBN1 KLF4 ACE RASIP1 TIAM1 STXBP6 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | 041a34080120c9f613373c20dcc366292f558040 |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | FAT4 SPTBN1 ACE RASIP1 CD36 MACF1 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | SPTBN1 KLF4 ACE RASIP1 STXBP6 VAV3 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ANGPT2 SPTBN1 ITGA10 PON2 RASIP1 NID1 SLC7A5 RPGR EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SPTBN1 KLF4 ACE RASIP1 STXBP6 MACF1 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | FAT4 SPTBN1 ACE RASIP1 CD36 MACF1 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | SPTBN1 KLF4 ACE RASIP1 STXBP6 VAV3 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | e77eba6172cabf85b8028638ed35299f2f079cd8 |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | FAT4 SPTBN1 ACE RASIP1 CD36 MACF1 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | a2b9d1cd291d17abddc3ee2e242121412c864b8b |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | SPTBN1 KLF4 ACE RASIP1 STXBP6 VAV3 ARHGAP18 SIPA1L2 EPAS1 HYAL2 | 4.91e-09 | 200 | 168 | 10 | 3372c488a39fe812fa94e4f0564594186fea3db5 |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.98e-08 | 172 | 168 | 9 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-08 | 180 | 168 | 9 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-08 | 180 | 168 | 9 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.08e-08 | 181 | 168 | 9 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.08e-08 | 181 | 168 | 9 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-08 | 182 | 168 | 9 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | SPTBN1 RASIP1 STXBP6 ARHGAP31 CD36 RIMS1 ARHGAP18 EPAS1 HYAL2 | 4.09e-08 | 187 | 168 | 9 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 4.09e-08 | 187 | 168 | 9 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.28e-08 | 188 | 168 | 9 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-08 | 188 | 168 | 9 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-08 | 188 | 168 | 9 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 4.48e-08 | 189 | 168 | 9 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 4.68e-08 | 190 | 168 | 9 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 4.90e-08 | 191 | 168 | 9 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 4.90e-08 | 191 | 168 | 9 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 5.12e-08 | 192 | 168 | 9 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-08 | 193 | 168 | 9 | ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1 | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.36e-08 | 193 | 168 | 9 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-08 | 193 | 168 | 9 | 7401e276b644b254c692160d0e7417ec28d50aa4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NES SPTBN1 ITGA10 SHROOM2 RASIP1 STXBP6 ARHGAP31 EPAS1 HYAL2 | 5.36e-08 | 193 | 168 | 9 | f582e939e3e08a8a3f71deec78c33715be8faa51 |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-08 | 193 | 168 | 9 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-08 | 193 | 168 | 9 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-08 | 194 | 168 | 9 | 0d72cb6183062d48488c73320e48044d070fbcac | |
| ToppCell | droplet-Lung-21m-Endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-08 | 194 | 168 | 9 | b45aebbc7641df0bf56d0c2e88821f1daf705449 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.60e-08 | 194 | 168 | 9 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-08 | 194 | 168 | 9 | 1a637809c0ec97374839c3476527e87eea75ed20 | |
| ToppCell | Endothelial-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.85e-08 | 195 | 168 | 9 | c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.12e-08 | 196 | 168 | 9 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 6.39e-08 | 197 | 168 | 9 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 6.39e-08 | 197 | 168 | 9 | 353b76ca3e2aa4b8f51396e7121c4baa114083a0 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.67e-08 | 198 | 168 | 9 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.67e-08 | 198 | 168 | 9 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 6.97e-08 | 199 | 168 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.97e-08 | 199 | 168 | 9 | 82758d0cee9387d002e3f68a6faa324134fb7564 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.97e-08 | 199 | 168 | 9 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.97e-08 | 199 | 168 | 9 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.97e-08 | 199 | 168 | 9 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.97e-08 | 199 | 168 | 9 | 307d29816a224193aa3d8c4540e128b2ad2e90b9 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-08 | 200 | 168 | 9 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-08 | 200 | 168 | 9 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.27e-08 | 200 | 168 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-08 | 200 | 168 | 9 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-08 | 200 | 168 | 9 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | distal-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | bc1781cff7a4602057a59ef65cf16c3a9459c628 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | 707148e01e961097819a05437a842b7d3bf72b0a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.27e-08 | 200 | 168 | 9 | ec9a18576a3d08ddfceb70d114c4ab861fbb0d08 | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | a8adf5902540f6bb15b72efbb9c389b59d67e001 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.27e-08 | 200 | 168 | 9 | 24e43d3d16d07571f77e0cd5b2e4758c6ff802cb | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | 3ef7b7728615710c691aed8977e2582f19692cf9 | |
| ToppCell | medial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | e4f390dfd4dd25600f0f7a17c5523283a5966e92 | |
| ToppCell | medial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.27e-08 | 200 | 168 | 9 | 4291b5453e98e20ec8150a96ccc865a5964bc645 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 7.27e-08 | 200 | 168 | 9 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-08 | 200 | 168 | 9 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.76e-07 | 160 | 168 | 8 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-07 | 166 | 168 | 8 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-07 | 166 | 168 | 8 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-07 | 176 | 168 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-07 | 180 | 168 | 8 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 4.71e-07 | 182 | 168 | 8 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 185 | 168 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 5.33e-07 | 185 | 168 | 8 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-07 | 186 | 168 | 8 | 8b316bfed39b91c15d5ae28d9261eb057f113796 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-07 | 186 | 168 | 8 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-07 | 186 | 168 | 8 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.55e-07 | 186 | 168 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-07 | 186 | 168 | 8 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-07 | 186 | 168 | 8 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-07 | 187 | 168 | 8 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 5.78e-07 | 187 | 168 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.78e-07 | 187 | 168 | 8 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-07 | 188 | 168 | 8 | 67c04f446fa4528b13a381622e88eb1f314cc6d5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.02e-07 | 188 | 168 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 6.02e-07 | 188 | 168 | 8 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| Drug | AC1L9KZG | 1.59e-06 | 49 | 168 | 6 | CID000447569 | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | RIMS3 ZNF230 CYRIB STAT5B PARD6B CACTIN STXBP6 SYNJ2 CD36 HCFC1 | 2.15e-06 | 197 | 168 | 10 | 4135_DN |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | NES SPTBN1 PPFIA3 AXIN1 NSD3 STAT5B VPS13A STAG3 EPAS1 HYAL2 | 2.25e-06 | 198 | 168 | 10 | 5688_DN |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.36e-06 | 199 | 168 | 10 | 6665_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | PRUNE2 RIMS3 SPTBN1 SLC11A1 L3MBTL1 NID1 DEPDC5 RPGR QSER1 HCFC1 | 2.36e-06 | 199 | 168 | 10 | 6240_UP |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; HL60; HT_HG-U133A | DCHS2 SYNM SPTBN1 STAT5B FANCA WDHD1 KCNJ5 CSPG4 ATP2A2 HYAL2 | 2.36e-06 | 199 | 168 | 10 | 2978_UP |
| Drug | glycidol | FAT4 TBX4 PCDHGB7 RIMS3 ITGA10 KLF4 LIPE SLC11A1 TIAM1 ARHGAP31 PAH NGF VAV3 OTOG | 9.92e-06 | 466 | 168 | 14 | ctd:C004312 |
| Drug | Oxpl | 1.02e-05 | 19 | 168 | 4 | CID000194296 | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 5469_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 3608_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | RANGAP1 ZNF230 PPM1A CACTIN WDHD1 CDC40 SYNJ2 ARHGAP12 ALG13 | 1.77e-05 | 199 | 168 | 9 | 2546_DN |
| Disease | interstitial cystitis (is_marker_for) | 1.58e-06 | 5 | 161 | 3 | DOID:13949 (is_marker_for) | |
| Disease | nephrosis (biomarker_via_orthology) | 5.78e-06 | 22 | 161 | 4 | DOID:2527 (biomarker_via_orthology) | |
| Disease | obesity (biomarker_via_orthology) | 1.70e-05 | 147 | 161 | 7 | DOID:9970 (biomarker_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 3.34e-05 | 67 | 161 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | Cardiovascular Diseases | 4.39e-05 | 36 | 161 | 4 | C0007222 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 8.84e-05 | 3 | 161 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | overactive bladder syndrome (is_marker_for) | 8.84e-05 | 3 | 161 | 2 | DOID:0070355 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 1.60e-04 | 93 | 161 | 5 | C1535926 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.59e-04 | 103 | 161 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | post-operative atrial fibrillation, response to surgery | 2.93e-04 | 5 | 161 | 2 | EFO_0009951, EFO_0009952 | |
| Disease | Staphylococcus aureus infection | 2.93e-04 | 5 | 161 | 2 | C1318973 | |
| Disease | Staphylococcal Infections | 2.93e-04 | 5 | 161 | 2 | C0038160 | |
| Disease | Coronary heart disease | 2.97e-04 | 24 | 161 | 3 | C0010068 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 4.24e-04 | 27 | 161 | 3 | DOID:8552 (is_marker_for) | |
| Disease | polycythemia (is_implicated_in) | 4.37e-04 | 6 | 161 | 2 | DOID:8432 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 4.72e-04 | 28 | 161 | 3 | DOID:3717 (is_marker_for) | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 5.03e-04 | 119 | 161 | 5 | EFO_0009268, MONDO_0004975 | |
| Disease | schizophrenia (implicated_via_orthology) | 5.30e-04 | 68 | 161 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | nephrosis (implicated_via_orthology) | 6.10e-04 | 7 | 161 | 2 | DOID:2527 (implicated_via_orthology) | |
| Disease | Mental Retardation, X-Linked 1 | 7.04e-04 | 32 | 161 | 3 | C2931498 | |
| Disease | platelet crit | NRIP1 ZBTB20 ATP13A1 RCN2 APOB ADGRV1 SIRPG STXBP6 TRABD CD36 SKAP1 OTUD4 SLC7A5 CNN2 | 7.57e-04 | 952 | 161 | 14 | EFO_0007985 |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 7.71e-04 | 33 | 161 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | microcephaly (is_implicated_in) | 8.11e-04 | 8 | 161 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 8.11e-04 | 8 | 161 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 9.21e-04 | 136 | 161 | 5 | DOID:9352 (is_marker_for) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 9.78e-04 | 80 | 161 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | urticaria, response to non-steroidal anti-inflammatory, angioedema | 1.04e-03 | 9 | 161 | 2 | EFO_0005531, EFO_0005532, EFO_0005533 | |
| Disease | liver cirrhosis (is_marker_for) | 1.07e-03 | 82 | 161 | 4 | DOID:5082 (is_marker_for) | |
| Disease | cortical surface area measurement | DCHS2 FAT3 SPTBN1 BEND3 ACTRT2 ADGRV1 ADAMTSL3 BBS9 PICALM AXIN1 ZNF106 STXBP6 ARHGAP31 ARHGAP12 UNC5C MACF1 QSER1 | 1.13e-03 | 1345 | 161 | 17 | EFO_0010736 |
| Disease | obsolete_red blood cell distribution width | NRIP1 KIAA0232 LRRC37A2 SCAMP2 APOB BBS9 PICALM CYRIB AXIN1 NSD3 ZC3H4 ZBED6 CD36 VPS13A SLC7A5 C1S CNN2 | 1.15e-03 | 1347 | 161 | 17 | EFO_0005192 |
| Disease | Schizophrenia | NRIP1 NTRK3 RIMS3 ADAMTSL3 ACE CRP UNC5C PAH SEPTIN7 ARHGAP18 ATP2A2 ENO2 NPAS1 | 1.16e-03 | 883 | 161 | 13 | C0036341 |
| Disease | colon cancer (biomarker_via_orthology) | 1.26e-03 | 39 | 161 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | cardiovascular system disease (is_marker_for) | 1.29e-03 | 10 | 161 | 2 | DOID:1287 (is_marker_for) | |
| Disease | Cryptogenic Tonic-Clonic Epilepsy | 1.29e-03 | 10 | 161 | 2 | C0751117 | |
| Disease | Epilepsy, Tonic-Clonic, Symptomatic | 1.29e-03 | 10 | 161 | 2 | C0751119 | |
| Disease | Epilepsy, Tonic-Clonic, Familial | 1.29e-03 | 10 | 161 | 2 | C0751118 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.29e-03 | 10 | 161 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Tonic-Clonic Epilepsy | 1.29e-03 | 10 | 161 | 2 | C0014549 | |
| Disease | Pulmonary arterial hypertension | 1.29e-03 | 10 | 161 | 2 | C2973725 | |
| Disease | eosinophil count | NRIP1 KIAA0232 SPTBN1 BEND3 ANKLE2 GTF3C4 PPM1A STAT5B STXBP6 TRABD SLC7A5 C1S CARD11 PRKCI LTB VAV3 CNN2 ALPK2 | 1.32e-03 | 1488 | 161 | 18 | EFO_0004842 |
| Disease | cholelithiasis | 1.39e-03 | 88 | 161 | 4 | EFO_0004799 | |
| Disease | Combined immunodeficiency | 1.46e-03 | 41 | 161 | 3 | C0494261 | |
| Disease | volumetric bone mineral density | 1.57e-03 | 42 | 161 | 3 | EFO_0007620 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 1.58e-03 | 11 | 161 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | response to cisplatin, response to antineoplastic agent | 1.58e-03 | 11 | 161 | 2 | GO_0072718, GO_0097327 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.79e-03 | 44 | 161 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | psoriasis (is_marker_for) | 1.79e-03 | 44 | 161 | 3 | DOID:8893 (is_marker_for) | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 1.94e-03 | 507 | 161 | 9 | C2239176 | |
| Disease | Celiac Disease | 2.17e-03 | 47 | 161 | 3 | C0007570 | |
| Disease | Primary Ciliary Dyskinesia | 2.17e-03 | 47 | 161 | 3 | C4551720 | |
| Disease | Leishmaniasis, Visceral | 2.22e-03 | 13 | 161 | 2 | C0023290 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 2.22e-03 | 13 | 161 | 2 | DOID:8805 (is_marker_for) | |
| Disease | Hyperlipoproteinemia Type IIb | 2.22e-03 | 13 | 161 | 2 | C1704417 | |
| Disease | Depressed mood | 2.22e-03 | 13 | 161 | 2 | C0344315 | |
| Disease | coronary artery disease (is_implicated_in) | 2.23e-03 | 100 | 161 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Kidney Failure, Chronic | 2.30e-03 | 48 | 161 | 3 | C0022661 | |
| Disease | Alzheimer's Disease | 2.31e-03 | 101 | 161 | 4 | C0002395 | |
| Disease | Malignant neoplasm of breast | NRIP1 COL7A1 RASGRF2 LRRC37A2 SHROOM2 MAMDC4 STAT5A LIPE LRRC37A FBXO8 SYNJ2 ZNF644 MKI67 MACF1 | 2.34e-03 | 1074 | 161 | 14 | C0006142 |
| Disease | Weight Gain | 2.40e-03 | 102 | 161 | 4 | C0043094 | |
| Disease | atrial fibrillation (is_implicated_in) | 2.58e-03 | 14 | 161 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | Leukemia, Myelocytic, Acute | 2.65e-03 | 173 | 161 | 5 | C0023467 | |
| Disease | sitting height ratio | 2.74e-03 | 51 | 161 | 3 | EFO_0007118 | |
| Disease | Hypertriglyceridemia | 2.97e-03 | 15 | 161 | 2 | C0020557 | |
| Disease | amenorrhea, response to antineoplastic agent | 2.97e-03 | 15 | 161 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Epilepsy | 3.05e-03 | 109 | 161 | 4 | C0014544 | |
| Disease | Congestive heart failure | 3.15e-03 | 110 | 161 | 4 | C0018802 | |
| Disease | Heart failure | 3.15e-03 | 110 | 161 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 3.15e-03 | 110 | 161 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 3.15e-03 | 110 | 161 | 4 | C0235527 | |
| Disease | Heart Decompensation | 3.15e-03 | 110 | 161 | 4 | C1961112 | |
| Disease | Myocardial Failure | 3.15e-03 | 110 | 161 | 4 | C1959583 | |
| Disease | Ciliopathies | 3.15e-03 | 110 | 161 | 4 | C4277690 | |
| Disease | diabetic retinopathy (is_marker_for) | 3.23e-03 | 54 | 161 | 3 | DOID:8947 (is_marker_for) | |
| Disease | Metastatic melanoma | 3.23e-03 | 54 | 161 | 3 | C0278883 | |
| Disease | Hyperlipoproteinemia Type IIa | 3.38e-03 | 16 | 161 | 2 | C0745103 | |
| Disease | sarcoidosis (is_implicated_in) | 3.38e-03 | 16 | 161 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | colorectal mucinous adenocarcinoma | 3.38e-03 | 16 | 161 | 2 | EFO_0009361 | |
| Disease | T-Cell Lymphoma | 3.38e-03 | 16 | 161 | 2 | C0079772 | |
| Disease | Idiopathic pulmonary arterial hypertension | 3.38e-03 | 16 | 161 | 2 | C3203102 | |
| Disease | phenylalanine measurement | 3.40e-03 | 55 | 161 | 3 | EFO_0005001 | |
| Disease | Carcinoma, Granular Cell | 3.81e-03 | 116 | 161 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.81e-03 | 116 | 161 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.81e-03 | 116 | 161 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.81e-03 | 116 | 161 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.81e-03 | 116 | 161 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.81e-03 | 116 | 161 | 4 | C0001418 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.81e-03 | 17 | 161 | 2 | C2936862 | |
| Disease | alkaline phosphatase measurement | ZBTB20 MOGAT2 ATP13A1 RBL2 SPTBN1 APOB AXIN1 RASIP1 SYNJ2 CD36 MACF1 SNX9 ALPK2 | 3.87e-03 | 1015 | 161 | 13 | EFO_0004533 |
| Disease | syndrome (implicated_via_orthology) | 4.27e-03 | 18 | 161 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | brain infarction | 4.27e-03 | 18 | 161 | 2 | EFO_0004277 | |
| Disease | Bardet-Biedl syndrome | 4.27e-03 | 18 | 161 | 2 | cv:C0752166 | |
| Disease | Hypercholesterolemia, Familial | 4.27e-03 | 18 | 161 | 2 | C0020445 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.42e-03 | 121 | 161 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.55e-03 | 61 | 161 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 4.76e-03 | 19 | 161 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | Acute Myeloid Leukemia, M1 | 4.96e-03 | 125 | 161 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.96e-03 | 125 | 161 | 4 | C1879321 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.25e-03 | 127 | 161 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Malaria | 5.27e-03 | 20 | 161 | 2 | C0024530 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATAPGFDNILFNADG | 1191 | Q6UXC1 | |
| TPGDAIISLDFGNQN | 406 | Q99814 | |
| AEGNPTDQAGFSEDR | 141 | Q86XL3 | |
| GIQAEASANDTFPNA | 1041 | Q9NP73 | |
| GQPATAFSQQDLLDG | 1181 | Q6UVK1 | |
| PGNFSADEAGAQLFA | 36 | P12821 | |
| ALDSPAVIFDNGSGF | 6 | Q8TDY3 | |
| EGEGFCSNSPLQVDN | 1091 | Q86TB3 | |
| GSSPDFNSQFGLVDI | 1151 | Q9HD20 | |
| LGFDSEGNVVNKPDS | 216 | O00178 | |
| VTQVFATDPDEGSNG | 2891 | Q6V0I7 | |
| DSDPDGDLAFTSGNI | 1906 | Q8WXG9 | |
| ISQPGNDFSTKDGDN | 416 | O15123 | |
| SDNQAFQAPGSPEEG | 66 | Q8TAB5 | |
| SAAGNLDEQTPGECF | 11 | P59037 | |
| GGFAPNILENSEALE | 211 | P09104 | |
| AFLNPEGDSGTEAEN | 341 | O14525 | |
| FSEGTDNKGNELPSA | 886 | Q9C0F0 | |
| FQGNGFPDRLASTEQ | 686 | Q96SN8 | |
| ANQDSGPGLSLEEFI | 161 | Q14257 | |
| ELDLSDNAFGPDGVQ | 116 | P46060 | |
| AQIGTADPGDFDQLT | 356 | Q5U651 | |
| EDKDSPFGNGQSNFS | 26 | Q96L73 | |
| AAADVNGFKPLSGNE | 216 | Q01804 | |
| AEAGSPDQEGFFNLL | 16 | Q8IVA1 | |
| DGLPSDQFAKGQDTV | 1321 | Q2KHR3 | |
| LAGGTNFSDTVQADP | 501 | Q92542 | |
| SQAEGGQTPLDAFQL | 406 | Q99742 | |
| IAQVSASDPDFGLNG | 471 | Q9Y5F8 | |
| SFESGQNGFIPSNEV | 326 | Q9BYG5 | |
| QGLDSGFVPSVQDFD | 106 | Q96SU4 | |
| PLNQTDINVGFDTGD | 251 | P48544 | |
| ENLTGFLEPGNFGES | 316 | Q08999 | |
| EDSQPSGQVASFFEA | 346 | Q5T5X7 | |
| RLEQAEGFPQGDNST | 286 | O75140 | |
| LFGGLANDSEDPKNN | 151 | P51610 | |
| DLNAFDVQASPNEGF | 56 | Q12891 | |
| NLADINDVSPSGGFV | 186 | O43474 | |
| PELAAGFDGNSIFNF | 771 | Q14667 | |
| PNISGEFGLDNFDSQ | 541 | P41743 | |
| EFGLDNFDSQFTNEP | 546 | P41743 | |
| GAKPANSAAENGFQE | 436 | O43194 | |
| QGAFSSLGDLSPQEN | 1356 | A6NM11 | |
| QGAFSSLGDLSPQEN | 1356 | A6NMS7 | |
| GIDDEDSFNNSPALG | 371 | Q86U70 | |
| QDLDFEVGGAAPFNR | 101 | P01138 | |
| GNLFPLLEGQDSGNS | 51 | Q16288 | |
| FGAELLSPSGQADVQ | 586 | O75145 | |
| DSRDGGFPNDASTEN | 56 | P0C7V8 | |
| PFSFETLNLGNENTD | 661 | Q92628 | |
| DLGSSNDGCPQLFQE | 181 | Q9Y468 | |
| DDLGLPNGLTFDAFS | 1106 | P14543 | |
| LSFSPEENFGDDSGL | 191 | Q9UJM8 | |
| EGSLTFNANPDEGVN | 141 | Q9NRD0 | |
| GNLETFLFPGTENQE | 641 | P48681 | |
| KGDVSNLDPNFSFEG | 221 | Q01650 | |
| NREEADNPNTGIGAF | 201 | Q8IVB5 | |
| EEDQNFNISGSAFPT | 46 | P48552 | |
| NGPDLQDFVSGDLAD | 41 | O43766 | |
| SGPESPFNNIFNDVD | 626 | Q8IWU2 | |
| AFLDPGNIESDLQAG | 71 | P49279 | |
| SDLSENIQAPTGEGF | 196 | Q8IXW0 | |
| INNFGDSINESEGIP | 486 | P46013 | |
| VVEFNPFENGDSGNL | 21 | Q8NFH4 | |
| QFSQEIGLASLGAPD | 301 | P00439 | |
| SLFPGFASQSDDDQV | 561 | Q3SYG4 | |
| NFTQGLVEDAPDGSD | 5076 | Q9UPN3 | |
| DASISKGDFQNPGDQ | 301 | Q8IWW6 | |
| PAAQQQEGSGFFLSE | 91 | Q6V1P9 | |
| GADSQFSDFLDGLGP | 1511 | Q86UR5 | |
| FGENDLFDQIPNSSG | 226 | Q3SYC2 | |
| GQNLGSFSPGEFDLI | 126 | Q8WXB1 | |
| AEGFDSANGINISPD | 216 | Q15165 | |
| NEAFIGLSLAPQGED | 651 | O95876 | |
| SNPDLFGEFLNSDSV | 976 | O14976 | |
| SPLFTLDANADIGNG | 2766 | P04114 | |
| AFTGREFDELNPSAQ | 651 | P16615 | |
| DAEDNTVSFLQPNGA | 106 | P16671 | |
| QEGRQFASDFLSPEA | 1201 | O15360 | |
| QGFPLDLGASFTEDA | 6 | O15169 | |
| SGNSEFFLDPESGEL | 3071 | Q8TDW7 | |
| DSGGAFAVQDPNDKT | 631 | P09871 | |
| EQDSFGGNFEGSQSL | 156 | P02741 | |
| NQEAFTDNPALGFVD | 236 | Q9NY37 | |
| TGNSIASIPDEAFNG | 351 | O94769 | |
| GSVAFPAENGVQDTE | 31 | Q16048 | |
| GSVAFPAENGVQDTE | 31 | Q9BQD1 | |
| LPDLNQDGFADVAVG | 556 | O75578 | |
| EPAGATESLQGQDLF | 131 | Q8TEP8 | |
| NTDNPFGDNNLLGTF | 196 | Q8WUQ7 | |
| ASTSEGLENFQGEDP | 141 | A6NN90 | |
| QTFFAVDDGPSLDQA | 1211 | Q02388 | |
| TDLEQGPNFFLDFEN | 11 | Q9NUQ9 | |
| ADEGLPANESFLNGN | 356 | O76039 | |
| CQGDDALPNGLDVTF | 106 | Q9Y512 | |
| DFGDASPRTNGQEAD | 461 | Q9BXL7 | |
| SGSLEFSIAGQPNDF | 451 | P48444 | |
| DIPEEANQNLSFGAT | 61 | Q9H9A6 | |
| EDNIAFFSSQGPGET | 316 | Q05469 | |
| SGEGTENQPDFTAAN | 31 | Q96DY7 | |
| NEGAPAVQGTDVEAF | 76 | Q96GU1 | |
| GNSLIVFDDDSGNPS | 1046 | Q6ZRI0 | |
| GIADGFQQPEAIEFS | 726 | Q92834 | |
| AEGGRNSFEENPDFE | 516 | Q5TD94 | |
| LQSSEPGDQGLFEAF | 931 | Q5ST30 | |
| FAAEPGNNELTVNEG | 11 | Q9Y5X1 | |
| LGLQEGSNNSSPVDF | 56 | Q96R06 | |
| NFAGLPAGEQDAEGN | 576 | Q96PX1 | |
| FLPDSFDAGSNQVLG | 266 | Q96DN5 | |
| NFQEGGQLASAAPDL | 2056 | Q8WUY3 | |
| EGFSGQIQFTAPLSD | 1271 | O15061 | |
| FNQPGVSDSELGGDD | 1026 | O15056 | |
| ESQFSDFLDGLGPAQ | 131 | Q9UJD0 | |
| EGTPNFTEEGLVNFS | 1166 | O14827 | |
| NDSEGAGELFQLEPS | 186 | Q96I59 | |
| AGSDEEGDNPFSAIQ | 1776 | Q8IZX4 | |
| EGDNPFSAIQLSESG | 1781 | Q8IZX4 | |
| DDEAFGEALQSPASG | 551 | Q96NG3 | |
| FKENDASNIDGFLGP | 181 | O60508 | |
| PGLLVFAGSSEQDAN | 21 | Q6PI97 | |
| ANKGEIGDATPFNDA | 991 | P30876 | |
| NNETAGPAFEEFLDL | 626 | Q9P2F8 | |
| DSLGQEPGAASFQND | 441 | Q13796 | |
| SGGDDQFPEQAELSG | 566 | Q96T21 | |
| QGGLAEFNPFSETNA | 31 | O15127 | |
| QVVPEFVNASADAGG | 706 | P51692 | |
| SDLAFGGSQQSPEVA | 571 | E7EW31 | |
| GNELSDFQTNVDPTG | 186 | Q9P1W8 | |
| SQDNFGFDLPAVEAA | 446 | Q01082 | |
| QVVPEFVNASADAGG | 701 | P42229 | |
| NPVDLFEANDLFESG | 101 | Q99439 | |
| PSAGLNVDFESVFGN | 481 | Q13492 | |
| GNPEAAGNSGFQLLD | 126 | Q96CW6 | |
| QQSEPLAATGTGDFN | 206 | P35443 | |
| VHPDSDFFGQEGETQ | 761 | P98169 | |
| RQVNGIDPNGDSAEF | 86 | Q8NFX7 | |
| GDTLLGTASPENEFN | 2011 | Q96RL7 | |
| QSLAENGLEPFSQDG | 66 | Q13009 | |
| NGLEPFSQDGTLEDF | 71 | Q13009 | |
| FIQPGDLGSGDSQED | 846 | Q9UJ98 | |
| SELDFAQGQPVAGTE | 1131 | Q9UJ98 | |
| ENGELFEFADTPGNL | 511 | Q8N271 | |
| NNQDFKGSAGAPSVE | 81 | P35813 | |
| SGDPQNLSDVDAFNL | 31 | Q9H4I3 | |
| IVDTPGFGDAVDNSN | 111 | Q16181 | |
| GDFLNDNAVEIPSFS | 336 | O75717 | |
| FNNGAPGSLENDENR | 216 | Q2M1Z3 | |
| NEAPEGNLGDFAEFQ | 226 | Q9UKN8 | |
| NLFGESAGDPQESIV | 121 | Q8N392 | |
| NNSDIAEDGGQTPYE | 36 | Q9BZ95 | |
| FAGNSPAREGEQDAA | 1271 | Q9UPT8 | |
| EQQFGPGAARDSQAE | 391 | Q9HC78 | |
| EPGENATLSYDQNDG | 901 | Q9H582 | |
| GEGFFPDQARAENLA | 381 | Q9NXH8 | |
| VGNGDIDTPFEVSQF | 206 | Q99598 | |
| NSLEDFFPQGADLET | 776 | P86452 | |
| SVHPNSDFFGQEGET | 756 | P98168 | |
| FFEQGDVPSQVEAGL | 116 | Q9UIE0 | |
| HGAEDEEAPSQQGFS | 51 | Q8NEK5 | |
| ENNPFAKGFRGSDDS | 241 | P57082 | |
| TANSDPGIAVGFDEF | 991 | P35442 | |
| SPRGFEAGFENEDNS | 561 | Q8IWY8 | |
| NDSFQVLQGDGPDSA | 571 | Q96T83 | |
| FPENLTNGATADNGD | 466 | Q6S545 | |
| SDIIDSSALNGGFQP | 411 | O95185 | |
| EQFGGNPFATATTDN | 271 | Q9H347 | |
| FFSEEGTGKENEPQQ | 876 | Q9H2Y7 | |
| FQPQGGDIGQDSSDD | 56 | Q86WV1 | |
| VDGNSQFGFSDQPSL | 1186 | Q6PFW1 | |
| QEPNSFFDGIGADAT | 11 | P08048 | |
| GTQFSDAEGLALPQD | 116 | Q06643 | |
| NLASGEVGFFPSDAV | 641 | Q9UKW4 | |
| SPQGSFLEDTTGEQF | 41 | P82987 |